Skip to main content

Lisinopril and Hydrochlorothiazide

NDC 71610-838 · Aphena Pharma Solutions - Tennessee, LLC

Generic nameLisinopril and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)HYDROCHLOROTHIAZIDE, LISINOPRIL
Strength12.5; 20 mg/1; mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

71610-838-30 — 30 TABLET in 1 BOTTLE (71610-838-30)

71610-838-53 — 60 TABLET in 1 BOTTLE (71610-838-53)

71610-838-60 — 90 TABLET in 1 BOTTLE (71610-838-60)

71610-838-70 — 120 TABLET in 1 BOTTLE (71610-838-70)

71610-838-80 — 180 TABLET in 1 BOTTLE (71610-838-80)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-671 — losartan potassium and hydrochlorothiazide, 71610-684 — Triamterene and Hydrochlorothiazide, 71610-697 — Hydrochlorothiazide, 71610-726 — Lisinopril, 71610-727 — LISINOPRIL, 71610-731 — LISINOPRIL, 71610-733 — LISINOPRIL, 71610-741 — Lisinopril, 71610-748 — LISINOPRIL, 71610-766 — LISINOPRIL, 71610-868 — Lisinopril and Hydrochlorothiazide Tablets, 72162-1035 — Irbesartan and Hydrochlorothiazide, 72162-1084 — Triamterene and Hydrochlorothiazide, 72162-1357 — Hydrochlorothiazide, 72162-1514 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 72162-1515 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 72162-1516 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 72162-1528 — Hydrochlorothiazide, 72162-1625 — Spironolactone and Hydrochlorothiazide, 72162-1700 — losartan potassium and hydrochlorothiazide, +1122 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.